Rasmussen encephalitis – Diagnostics – Overview of Information and Clinical Research

Rasmussen encephalitis is a rare brain condition that usually begins with seizures in childhood, and finding the right diagnosis early can make a real difference in how families navigate treatment choices and plan for the future.

Introduction: Who Should Undergo Diagnostics

If your child experiences a seizure for the first time, it is essential to see a healthcare provider as soon as possible. This is especially important if the seizures become more frequent over time or if you notice other changes in your child’s abilities or behavior. Rasmussen encephalitis typically affects children between the ages of 2 and 10, though around 10% of cases occur in adolescents and adults.^[1]^[2]

Parents and caregivers should seek medical evaluation when seizures are accompanied by additional warning signs. These signs might include mild weakness in an arm or leg, changes in speech or language abilities, or noticeable decline in thinking skills or school performance. Because Rasmussen encephalitis is so rare—affecting only about 2 out of every 10 million people—doctors may not immediately suspect it.^[1] However, when seizures do not respond well to medication and are combined with neurological symptoms affecting one side of the body, further investigation becomes necessary.

Children who were previously healthy and then begin experiencing focal seizures (seizures that start in one area or one side of the brain) should be carefully monitored. Sometimes these seizures can manifest as twitching in just one hand or arm, or they might involve changes in awareness. About half of people with Rasmussen encephalitis develop a particularly striking type of seizure called epilepsia partialis continua, where continuous twitching occurs in the face, arm, or leg on one side of the body every few seconds or minutes.^[1]^[2]

It is also important to note that Rasmussen encephalitis usually starts in otherwise healthy individuals. The disease does not discriminate based on family history or prior health conditions. If you notice that your child’s seizures are becoming difficult to control with standard anti-seizure medications—a situation doctors call intractable or drug-resistant epilepsy—this is another strong reason to pursue comprehensive diagnostic testing.^[2]

⚠️ Important

Early diagnosis of Rasmussen encephalitis can be challenging because the condition is extremely rare and symptoms may initially resemble more common forms of epilepsy. If your child’s seizures are not responding to medication and you observe progressive weakness or cognitive changes on one side of the body, do not hesitate to ask for a second opinion or request a referral to a specialized epilepsy center. Early and accurate diagnosis can help families understand what to expect and explore treatment options sooner.

Diagnostic Methods

Diagnosing Rasmussen encephalitis involves a combination of clinical observation, neurological examination, and several specialized tests. Because the condition is so uncommon, healthcare providers rely on multiple pieces of evidence to confirm the diagnosis and rule out other conditions that might cause similar symptoms.^[1]

Medical History and Neurological Examination

The diagnostic process typically begins with a detailed review of the patient’s medical history and a thorough neurological evaluation. Doctors will ask about when the seizures started, how often they occur, what they look like, and whether there have been any changes in the child’s abilities or behavior over time. During the neurological exam, the healthcare provider will assess motor skills, coordination, vision, speech, and cognitive function to identify any signs of weakness or decline affecting one side of the body.^[5]

Magnetic Resonance Imaging (MRI)

Magnetic resonance imaging, or MRI, is one of the most important diagnostic tools for Rasmussen encephalitis. An MRI uses magnets and radio waves to create detailed pictures of the brain without using radiation. In patients with Rasmussen encephalitis, MRI scans can reveal shrinking or loss of brain tissue—called atrophy—on one side of the brain. This atrophy typically becomes more visible as the disease progresses.^[1]^[6]

However, it is important to understand that an MRI taken very early in the disease may appear normal or show only subtle changes. In the early stages, the MRI might show swelling in one hemisphere of the brain, and signs of atrophy may not yet be apparent. This is why repeated imaging over time can be helpful, as the progressive nature of the brain tissue loss becomes clearer with follow-up scans.^[6]

Electroencephalogram (EEG)

An electroencephalogram, or EEG, is a test that records the electrical activity of the brain using sensors placed on the scalp. Because seizures are usually the first and most prominent symptom of Rasmussen encephalitis, an EEG is particularly useful for understanding the type and location of abnormal brain activity. The test can show patterns of slowing or seizure activity that are localized to one area, one region, or an entire side of the brain, depending on the stage of the disease.^[6]

The EEG is a non-invasive and painless test, though it can take some time to complete. In some cases, doctors may recommend prolonged EEG monitoring to capture seizure activity over hours or even days. This extended monitoring helps doctors see exactly how the brain behaves during a seizure and between seizures, which can provide valuable clues about the extent and location of the problem.^[5]

Computed Tomography (CT) Scan

A computed tomography scan, or CT scan, is another imaging test that uses X-rays to create cross-sectional pictures of the brain. While CT scans are not as detailed as MRIs for viewing soft tissues like the brain, they can still reveal important changes such as brain atrophy or abnormalities in brain structure. CT scans are faster than MRIs and may be used in emergency situations or when an MRI is not immediately available.^[5]

Blood Tests and Spinal Tap (Lumbar Puncture)

Routine blood tests may be performed to look for signs of infection, inflammation, or other abnormalities that could explain the symptoms. A complete blood count and other lab work can provide information about the body’s overall functioning and help rule out other causes of seizures.^[8]

In some cases, doctors may also recommend a spinal tap or lumbar puncture. During this procedure, a small amount of fluid is collected from around the spinal cord and analyzed. This test can help diagnose or rule out infections or other inflammatory conditions affecting the brain and nervous system. While a lumbar puncture can provide useful information, it is not always able to definitively diagnose Rasmussen encephalitis on its own.^[8]

Brain Biopsy

In certain situations, a brain biopsy may be considered to confirm the diagnosis of Rasmussen encephalitis. A biopsy involves removing a small sample of brain tissue for examination under a microscope. This allows doctors to look for specific signs of inflammation and immune cell activity that are characteristic of Rasmussen encephalitis. Biopsies can reveal infiltration of immune cells called T lymphocytes, along with other changes in brain tissue that support the diagnosis.^[3]

Because a brain biopsy is an invasive procedure that carries some risks, it is typically reserved for cases where the diagnosis is uncertain and other tests have not provided clear answers. The decision to perform a biopsy is made carefully, weighing the potential benefits of a definitive diagnosis against the risks of the procedure itself.^[3]

Neuropsychological Testing

As part of the comprehensive evaluation, doctors may recommend neuropsychological testing. These tests assess various aspects of brain function, including memory, thinking skills, language abilities, and problem-solving. Because Rasmussen encephalitis can cause progressive cognitive decline, neuropsychological testing helps establish a baseline of the child’s abilities and can track changes over time. This information is also valuable for planning educational support and rehabilitation services.^[7]

Understanding how the disease affects different areas of the brain—particularly whether it involves the side of the brain responsible for language and memory—can help families and healthcare teams anticipate challenges and plan appropriate interventions.

⚠️ Important

Because Rasmussen encephalitis is so rare, it can sometimes take time to reach a definitive diagnosis. Some children may initially be diagnosed with other forms of epilepsy before the full picture becomes clear. If you feel uncertain about your child’s diagnosis or treatment plan, seeking care at a specialized epilepsy center or requesting a consultation with experts in rare neurological conditions can provide valuable reassurance and guidance.

Diagnostics for Clinical Trial Qualification

While there is limited information available specifically about diagnostic criteria used to qualify patients for clinical trials in Rasmussen encephalitis, the general diagnostic methods described above form the foundation for determining eligibility. Clinical trials for rare diseases like Rasmussen encephalitis typically require careful documentation of the diagnosis through a combination of clinical symptoms, imaging findings, EEG results, and sometimes biopsy confirmation.^[3]

Researchers conducting clinical trials need to ensure that participants truly have the condition being studied. This often means that patients must meet specific diagnostic criteria, which may include evidence of progressive unilateral brain inflammation, drug-resistant seizures affecting one hemisphere, and progressive neurological decline consistent with Rasmussen encephalitis. Imaging studies showing characteristic patterns of brain atrophy and EEG findings demonstrating focal or hemispheric seizure activity are typically essential components of the enrollment process.^[3]

Given the rarity of Rasmussen encephalitis—with only about two new cases per year identified even in large epilepsy centers—clinical trials for this condition are uncommon and may involve only a small number of participants. Families interested in clinical trial participation should discuss this option with their child’s neurologist or epileptologist, who can help identify any available studies and determine whether the child meets the eligibility requirements.^[2]

Participation in a clinical trial may offer access to experimental treatments or therapies that are not yet widely available. However, it is important to understand that clinical trials are research studies designed to gather information, and there is no guarantee that an experimental treatment will be effective. Families considering this option should carefully review the potential benefits and risks with their healthcare team and make an informed decision based on their child’s individual circumstances.

Prognosis and Survival Rate

Prognosis

The outlook for children with Rasmussen encephalitis depends on several factors, including how early the condition is diagnosed, the severity of seizures, and the extent of brain damage that occurs before treatment is initiated. For most people with Rasmussen encephalitis, the condition is most severe during the first eight to 12 months after symptoms begin. During this acute phase, the inflammation is active and symptoms tend to worsen progressively, with increasing seizure frequency and advancing neurological decline.^[1]

After this initial period, the progression of the disease typically slows or stops, and the condition enters what doctors call the residual or chronic stage. During this stage, the active inflammation subsides, but the neurological damage that has already occurred is permanent. This means that while seizures may become less frequent or even stop in some cases, the physical, cognitive, and functional impairments remain.^[1]^[6]

Children who undergo surgical treatment, such as hemispherectomy (a procedure that disconnects the affected side of the brain from the unaffected side), often experience significant improvement in seizure control. Many children become seizure-free or have a substantial reduction in seizure frequency following surgery. However, surgery does not reverse the brain damage that occurred before the procedure, and children typically continue to have some degree of weakness on one side of the body, as well as vision and cognitive challenges depending on which hemisphere was affected.^[7]

The long-term prognosis varies widely from person to person. Some individuals are left with significant disabilities, including paralysis or severe motor impairment on one side of the body, persistent cognitive difficulties, and speech or language problems. Others, particularly those who receive early treatment, may experience less severe long-term disability and are able to participate in school, work, and daily activities with appropriate support and rehabilitation.^[6]

Despite the challenges, many families report that with intensive rehabilitation and support, children can make meaningful progress. Physical therapy, occupational therapy, speech therapy, and educational interventions can help children adapt to their limitations and maximize their remaining abilities. The presence of a supportive community and access to specialized care can also significantly impact quality of life and functional outcomes over time.^[15]

Survival Rate

Specific survival rate statistics for Rasmussen encephalitis are not widely reported in the available medical literature. However, the condition itself is not typically considered life-threatening in terms of causing death directly. The main risks to health and survival are related to complications from severe, uncontrolled seizures and the potential long-term effects of progressive brain damage.

Most individuals with Rasmussen encephalitis survive into adulthood, though they may live with significant neurological impairments and disabilities. The quality of life and long-term outcomes depend heavily on the effectiveness of seizure control, the extent of brain damage, and the availability of comprehensive medical care and rehabilitation services.

#1 Clinical Trials Search in Europe